Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study
PATCHES
Clinical and Imaging Characteristics in Patients Suspected of Dural Leakage Before and After Treatment
2 other identifiers
observational
400
1 country
1
Brief Summary
The goal of this observational study is to learn about the effects of a low-pressure environment on the brain in patients with intracranial hypotension and to potentially improve diagnostics and treatment of this condition. The primary objective will be: To investigate the change in clinical biomarkers measured before and after successful treatment. The secondary objectives will be: To investigate if clinical biomarkers can predict the outcome of treatment. Participants undergoing standard treatment for intracranial hypotension will undergo additional examinations and surveys and will be followed up for a year for the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2024
CompletedFirst Submitted
Initial submission to the registry
January 28, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2029
February 6, 2025
February 1, 2025
4.8 years
January 28, 2025
February 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To investigate the change in clinical biomarkers measured before and after successful treatment.
From enrollment to 1 year post-treatment.
Study Arms (2)
Patients with suspected Intracranial Hypotension
Patients will be included in the cohort if suspected of intracranial hypotension. The group will therefore be subgrouped into patients with spontaneous intracranial Hypotension, post-lumbar puncture headache, and patients suspected but not demonstrated with intracranial hypotension.
Control Group
Group consisting of healthy control participants.
Eligibility Criteria
Patients at the Danish Headache Center with suspected intracranial hypotension
You may qualify if:
- Age 18-80.
- Patients with a suspected intracranial hypotension diagnosis.
- Participants must read and understand the Danish language or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study.
- Age 18-80.
- Healthy people who do not suffer from any form of primary headache except infrequent tension-type headache.
- Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.
You may not qualify if:
- Pregnant or breastfeeding females
- Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases.
- The patient has a disease, takes medication, or abuses alcohol or drugs that could, in the investigator´s opinion interfere with the assessments of safety, tolerability, or efficacy, or interfere with the conduct or interpretation of the study.
- The patient is, in the investigator´s opinion, unlikely to comply with the protocol or is unsuitable for any reason.
- Pregnant or breastfeeding females
- Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases.
- The participant has a disease, takes medication, or abuses alcohol or drugs that could, in the investigator´s opinion interfere with the interpretation of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Danish Headache Center
Glostrup Municipality, Copenhagen, 2600, Denmark
Biospecimen
Blood and cerebrospinal fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henrik W Schytz, MD, Ph.D. DMSc
Danish Headache Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Consultant Neurologist
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 3, 2025
Study Start
December 10, 2024
Primary Completion (Estimated)
September 30, 2029
Study Completion (Estimated)
September 30, 2029
Last Updated
February 6, 2025
Record last verified: 2025-02